Busulfan and Melphalan Conditioning in Multiple Myeloma
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether intravenous busulfan and melphalan as a
conditioning regimen is effective in the treatment of multiple myeloma undergoing autologous
stem cell transplantation.